Ratings Sensus Healthcare, Inc.

Equities

Market Closed - Nasdaq Other stock markets 04:00:00 2025-07-16 pm EDT			5-day change	1st Jan Change
4.330 ^USD	+3.10%		-5.66%	-37.43%

May. 23	Sensus Healthcare, Inc., Q1 2025 Earnings Call, May 15, 2025
May. 15	Tranche Update on Sensus Healthcare, Inc.'s Equity Buyback Plan announced on August 8, 2023.	CI

On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.
From a short-term investment perspective, the company presents a deteriorated fundamental configuration.

Its core activity has a significant growth potential and sales are expected to surge, according to Standard & Poor's' forecast. Indeed, those may increase by 51% by 2027.
Sales forecast by analysts have been recently revised upwards.
Analysts covering this company mostly recommend stock overweighting or purchase.
The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
Consensus analysts have strongly revised their opinion of the company over the past 12 months.
The group usually releases upbeat results with huge surprise rates.

For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
For the past year, analysts have significantly revised downwards their profit estimates.
For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.
Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.

Source: Surperformance

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Fundamentals (Composite)	Global Valuation (Composite)	Capi.($)
SENSUS HEALTHCARE, INC.	-	-	69.07M
SARTORIUS AG			15.37B
QUIDELORTHO CORPORATION		-	1.89B
INNER MONGOLIA FURUI MEDICAL SCIENCE CO., LTD.		-	1.36B
SHANGHAI MICROPORT EP MEDTECH CO., LTD.			1.3B
BIOTAGE AB			1.17B
SHANGHAI AOHUA PHOTOELECTRICITY ENDOSCOPE CO., LTD.		-	859M
REVENIO GROUP OYJ			845M
CELLAVISION AB			444M
Average			2.59B
Weighted average by Cap.